Chronic Myelomonocytic Leukemia - 3D chip model feasibility study

01.10.2024 - 30.09.2025
Research funding project

Chronic Myelomonocytic Leukemia (CMML) poses a significant challenge in clinical management due to its heterogeneity and limited treatment options. In this study, we employ rapid prototyping techniques to establish a 3D model system utilizing bone marrow and blood samples from CMML patients. We benchmark five matrix types for CMML cell growth, explore endothelial cell interactions, and compare mononuclear versus CD34 sorted cells in standard and serum reduced media.

People

Project leader

Institute

Donation

  • Gesellschaft zur Erforschung der Biologie und Behandlung von Tumorkrankheiten

Research focus

  • Biological and Bioactive Materials: 100%

External partner

  • Sigmund Freud PrivatUniversität
  • Gesellschaft zur Erforschung der Biologie und Behandlung von Tumorkrankheiten

Publications